These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 7579458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.
    Maes B, Vanhentenrijk V, Wlodarska I, Cools J, Peeters B, Marynen P, de Wolf-Peeters C.
    Am J Pathol; 2001 Jun 15; 158(6):2185-93. PubMed ID: 11395396
    [Abstract] [Full Text] [Related]

  • 7. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC.
    Leuk Lymphoma; 1998 May 15; 29(5-6):507-14. PubMed ID: 9643564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY.
    Blood; 1997 Feb 15; 89(4):1394-404. PubMed ID: 9028963
    [Abstract] [Full Text] [Related]

  • 10. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G.
    Blood; 1996 Sep 01; 88(5):1765-70. PubMed ID: 8781433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The t(2;5) in human lymphomas.
    Kadin ME, Morris SW.
    Leuk Lymphoma; 1998 Apr 01; 29(3-4):249-56. PubMed ID: 9684923
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L, Parc P, Hassoun J, Birnbaum D.
    J Pathol; 1996 Feb 01; 178(2):128-32. PubMed ID: 8683377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis.
    Trümper L, Daus H, Merz H, von Bonin F, Loftin U, Cochlovius C, Möller P, Feller AC, Pfreundschuh M.
    Ann Oncol; 1997 Feb 01; 8 Suppl 2():83-7. PubMed ID: 9209648
    [Abstract] [Full Text] [Related]

  • 20. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R, Pugh WC, Waasdorp M, Morris W, Cabanillas F, Chan PK, Sarris AH.
    Hematopathol Mol Hematol; 1998 Feb 01; 11(3-4):173-83. PubMed ID: 9844824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.